MyAverix Finance
NS · Pharmaceuticals
Lincoln Pharmaceuticals Ltd (LINCOLN)
Pharmaceuticals & Biotechnology
Lincoln Pharmaceuticals Ltd (LINCOLN) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $12.13B, P/E ratio is 13.80, net margin is 13.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LINCOLN
Lincoln Pharmaceuticals Ltd (LINCOLN) — FAQ
What is Lincoln Pharmaceuticals Ltd's market cap?
Lincoln Pharmaceuticals Ltd (LINCOLN) has a reported market cap of $12.13B (data as of 2026-07-10).
What is LINCOLN's P/E ratio?
The price-to-earnings (P/E) ratio for Lincoln Pharmaceuticals Ltd (LINCOLN) is 13.80 (data as of 2026-07-10).
Does Lincoln Pharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Lincoln Pharmaceuticals Ltd (LINCOLN). Check the MyAverix Finance app for the latest dividend data.
What sector is Lincoln Pharmaceuticals Ltd in?
Lincoln Pharmaceuticals Ltd (LINCOLN) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is LINCOLN listed on?
LINCOLN is listed on NS.
What is Lincoln Pharmaceuticals Ltd's net margin?
Lincoln Pharmaceuticals Ltd (LINCOLN) reports a net margin of 13.5% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.